Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors Meeting Abstract


Authors: Melero, I.; Segal, N. H.; Saro, J.; Ros, W.; Martinez-Garcia, M.; Argiles, G.; Moreno, V.; Ponce, S.; Marabelle, A.; Cleary, J. M.; Hurwitz, H. I.; Eder, J. P.; Jamois, C.; Andersson, E.; Bouseida, S.; Sandoval, F.; Bacac, M.; Nayak, T.; Karanikas, V.; Calvo, E.
Abstract Title: Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors
Meeting Title: 42nd ESMO Congress (ESMO 2017)
Journal Title: Annals of Oncology
Volume: 28
Issue: Suppl. 5
Meeting Dates: 2017 Sep 8-12
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2017-09-01
Start Page: mdx363.020
Language: English
ACCESSION: WOS:000411324000163
PROVIDER: wos
DOI: 10.1093/annonc/mdx363.020
Notes: Meeting Abstract: 104P -- Appears on page 28 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neil Howard Segal
    209 Segal